You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GH Sale Disclosure
Talasaz Amirali · SEC Form 4 · Filed Aug 24, 2026
Sale
Calculated transaction value
$1.52M
Talasaz Amirali Co-chief Executive Officer
GH
Transaction date
Aug 21, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed 3 days later
GH daily price context
Close on/before transaction
$170.69
Aug 21, 2026
First close after public filing
$164.92
Aug 25, 2026
30-day return after filing
+6.91%
Through Sep 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,023 shares @ $168.2
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001753159-26-000020
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$6.34M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Guardant Health, Inc. GH | Sale | Aug 21, 2026 | $3.53M |
| Guardant Health, Inc. GH | Sale | Aug 21, 2026 | $1.29M |
| Guardant Health, Inc. GH Current | Sale | Aug 21, 2026 | $1.52M |